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Background: Plasmodium knowlesi was identified as the fifth major malaria parasite in humans. It presents severe
clinical symptoms and leads to mortality as a result of hyperparasitemia in a short period of time. This study aimed
to improve the current understanding of P. knowlesi and identify potential biomarkers for knowlesi malaria.
Methods: In the present study, we have employed two-dimensional gel electrophoresis-coupled immunoblotting
techniques and mass spectrometry to identify novel circulating markers in sera from P. knowlesi-infected patients.
Specifically, we have compared serum protein profiles from P. knowlesi-infected patients against those of healthy or
P. vivax-infected individuals.
Results: We identified several immunoreactive proteins in malarial-infected subjects, including alpha-2-HS glycoprotein
(AHSG), serotransferrin (TF), complement C3c (C3), hemopexin (HPX), zinc-2-alpha glycoprotein (ZAG1), apolipoprotein
A1 (Apo-A1), haptoglobin (HAP), and alpha-1-B-glycoprotein (A1BG). However, only TF and HPX displayed enhanced
antigenicity and specificity, suggesting that they might represent valid markers for detecting P. knowlesi infection.
Additionally, six P. knowlesi-specific antigens were identified (K15, K16, K28, K29, K30, and K38). Moreover, although HAP
antigenicity was observed during P. vivax infection, it was undetectable in P. knowlesi-infected subjects.
Conclusions: We have demonstrated the application of immunoproteomics approach to identify potential candidate
biomarkers for knowlesi malaria infection.
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Malaria has been known to be caused by major human
malaria parasites – Plasmodium falciparum, P. vivax, P.
malariae and P. ovale. P. knowlesi which was initially
found in only long-tailed (Macaca fascicularis) and pig-
tailed (Macaca nemestrina) macaques [1]. It has been
recognized as the fifth species of Plasmodium that
causes malaria infection in humans [2,3]. Several cases
of P. knowlesi infection in humans were reported in
Malaysian Borneo, Myanmar, Philippines, Singapore, and
Thailand [1,4], supporting the notion that P. knowlesi
represents a major cause of malaria in Southeast Asia. P.* Correspondence: chenyeng@um.edu.my; subash@unimap.edu.my
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unless otherwise stated.knowlesi is the only malaria species that has a 24-hour
asexual reproduction cycle (quotidian). Therefore, pa-
tients infected with P. knowlesi can easily reach lethal
parasite densities in a relatively short period of time
[5]. Respiratory distress, renal dysfunction, jaundice,
hypoglycaemia and severe anaemia are the general clin-
ical manifestations of severe malaria infection [6]. In
addition, the severity of knowlesi malaria was found to
be associated with hyperparasitemia and this has been re-
ported in Malaysia and in other Southeast Asia regions [5,6].
Like other malaria species, identification of P. knowlesi
infection is achieved through examination of thick and
thin blood films followed by Giemsa microscopy. This
method uses specific morphological characteristics to
differentiate parasites. However, accurate diagnosis of P.
knowlesi by microscopy is often limited by the fact that
P. knowlesi bares strong morphological resemblance tohis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(erythrocytic stages) [7]. Thus, diagnosis of P. knowlesi
usually requires molecular detection methods, which are
performed in reference laboratories. In this regard, polymer-
ase chain reaction (PCR) and molecular characterization
currently represent the most reliable detection methods for
P. knowlesi infection. Nevertheless, PCR-based techniques
are not suitable for routine identification, since this method
requires parasite DNA and is time consuming. In addition,
P. knowlesi is frequently misdiagnosed as P. malariae
through PCR and conventional microscopy [5]. Currently,
there are no commercially available malaria rapid diagnostic
tests are designed specifically for P. knowlesi detection.
Although Plasmodium lactate dehydrogenase (pLDH) assay
is more reliable in detecting P. knowlesi infection, the cross-
reactivity of P. knowlesi with P. falciparum-specific and P.
vivax-specific pLDH has been shown [8]. Therefore, as
stated by Cox-Singh et al. [5], there is currently a funda-
mental need for effective and practical diagnostic methods,
which will not only contribute to reduced malaria-
associated complications and mortality, but also facilitate
global malaria control.
Notably, host biomarkers can be used to assess the risk
of infection, examine protection against active diseases,
or to determine therapeutic responses. Indeed, employ-
ing gene profiling, Schaecher et al. [9] has identified host
biomarkers that can differentiate between lethal and
non-lethal blood stages of murine malaria. Serum sam-
ples collected during the course of infection were uti-
lized to analyze differential protein expression patterns,
which were found to correlate with the degree of infection.
Such data can provide insight into the cell regulatory
mechanisms that participate in pathogenesis, immune re-
sponses and host recovery. Moreover, the identified pro-
teins could be measured by serological tests to detect
variants of malaria parasites while conducting epidemio-
logical studies or implementing control programs. For ex-
ample, serum angioprotein I and angioprotein 2/L have
been suggested as diagnostic and prognostic biomarkers as
well as potential therapeutic targets in cerebral malaria
[10]. In the present study, we have examined the proteomic
profiles of serum from P. knowlesi-infected patients to
identify distinctive immunological protein features. Specif-
ically, we have compared serum protein profiles from P.
knowlesi-infected patients against those of healthy or P.
vivax-infected subjects. Our findings have the potential to
enhance our understanding of P. knowlesi and might con-
tribute to the development of novel diagnostic approaches.
Methods
Clinical samples
From 200 serum samples previously screened for malaria
parasites [11], we selected 15 samples for the current
study. Notably, these samples corresponded to patientswho were newly diagnosed with either P. knowlesi (n = 9,
parasitemia range: 0.04-22.80%, age range: 29–55 years,
Male, Malaysian) or P. vivax (n = 6, parasitemia range:
0.10-0.50%, age range: 29–50 years, Male, non-
Malaysian Asian). Additionally, 23 serum samples were
collected from normal healthy individuals and were
used as a control group (age range: 29–50 years, Male,
Malaysian). All samples were obtained with patients’
written consent, and this study was approved by the
University of Malaya Medical Centre Ethical Committee
in accordance with ICH–GCP guidelines for good clinical
practice and the Declaration of Helsinki (PPUM/MDU/
300/04/03).
Two-dimensional electrophoresis (2-DE)
Two-dimensional electrophoresis (2-DE) was performed
as previously described by Chen et al. [12]. Briefly, 10 μl
of unfractionated whole human serum (either individual
serum or pooled sera) was subjected to isoelectric focus-
ing using 13-cm rehydrated precast immobilized dry
strips (pH 4–7) (GE Healthcare Bio-Sciences, Uppsala,
Sweden). For the second dimension, focused sample
within the strips was subjected to electrophoresis using
an 8–18% gradient polyacrylamide gel in the presence of
sodium dodecyl sulphate (SDS). All samples were ana-
lyzed in duplicate. The 2-DE gels were silver stained as
described by Heukeshoven and Dernick [13]. For mass
spectrometric analysis, gels were stained using Coomassie
Brilliant Blue (CBB) or a modified mass spectrometry
(MS) silver staining method, as described by Shenvchenko
et al. [14]. CBB gel plugs were used instead of silver-
stained gel plugs when a higher peptide concentration was
expected from in-gel digestion.
Mass spectrometry analysis and database search
Selected spots were excised and subjected to in-gel tryptic
digestion using the commercially available Proteo
Extract™ All-in-One Trypsin Digestion Kit (Calbiochem,
Darmstadt, Germany). Mass spectrometry (MS) analysis
was performed at the Faculty of Biological Sciences
Proteomic Centre, National University of Singapore.
After digestion, the resulting peptides were mixed with
CHCA matrix solution (5 mg/ml of cyano-4-hydroxy-
cinamic acid in 0.1% trifluoroacetic acid [TFA] and 50%
acetonitrile [ACN]) in 1:2 ratio and spotted onto a matrix-
assisted laser desorption/ionization (MALDI) target plate.
Peptide mass spectra were obtained using an ABI 4800
Proteomics Analyzer MALDI-TOF/TOF Mass Spectrom-
eter (Applied Biosystems, Foster City, CA, USA). For MS
analysis, 1,000 shots were accumulated for each sample.
MS data were automatically obtained with the five most
intense ions for MS/MS. Peptides were subsequently sub-
jected to MS/MS analyses using air with collision energy
of 2 kV and a collision gas pressure of ~1×10−6 Torr. The
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2,000 to 3,000 shots, depending on the quality of the
spectra. The Mascot search engine (version 2.1; Matrix
Science, London, UK) was used to analyze all of the
tandem MS results. Also, GPS Explorer™ software (ver-
sion 3.6; Applied Biosystems) was employed in combin-
ation with the Mascot search engine for peptide
identification. The search parameters allowed for N-
terminal acetylation, C-terminal cysteine carbamidometh-
ylation (fixed modification), and methionine oxidation
(variable modification). The peptide and fragment mass
tolerance were set to 100 ppm and ±0.2 Da, respectively.
Moreover, peptide mass fingerprinting (PMF) parameters
for the data search were as follows: one missed cleavage
allowed in trypsin digest; monoisotropic mass value;
±0.1 Da peptide mass tolerance; and 1+ peptide charge
state. Initial protein identification was determined by
comparing peptide masses to a database of tryptic pep-
tides from known proteins (ProteinPilot proteomics soft-
ware [4800] Proteomic Analyzer; Applied Biosystems),
and a score was assigned based on similarity to theoretic-
ally and experimentally determined masses. Analyses were
conducted using International Protein Index (http://www.
ebi.ac.uk/IPI/), NCBI, Unigene (version 3.38), and Plas-
moDB (version 8.0; http://plasmodb.org/plasmo/) data-
bases for human proteomics. There were a total of 10,719
entries included in the database search. Search scores
of >82 (Mascot NCBI database) or >30 (Mascot search
engine using PlasmoDB) were considered as significant.
Immunoblotting
For immunoblotting, we analyzed 10 μl of pooled,
unfractionated human serum. Following electrophoresis,
the 2-DE gels for the pooled serum samples were
grouped into five categories: (a) normal pooled sera
probed with normal pooled sera, (b) normal pooled sera
probed with P. knowlesi pooled sera, (c) P. knowlesi
pooled sera probed with normal pooled sera, (d) P.
knowlesi pooled sera probed with P. knowlesi pooled
sera, (e) P. knowlesi pooled sera probed with P. vivax
pooled sera. Each of the gels was transferred onto nitro-
cellulose membrane using the Multiphor II Novablot
semi-dry system (GE Healthcare, Sweden). The blotted
nitrocellulose membranes were then blocked with
SuperBlock (Pierce, USA) and washed three times with
Tris-buffered saline–Tween 20 (TBST). The membranes
were subsequently incubated overnight (4°C) with the
indicated primary antibodies, which corresponded to P.
knowlesi infection, P. vivax infection, or normal healthy
controls (all diluted at 1:50). After another washing step,
the membranes were incubated with monoclonal anti-
human Immunoglobulin M (IgM) conjugated to horse-
radish peroxidase (HRP) (Invitrogen, USA) at a dilution
of 1:6,000 for 1 h at room temperature. The resultingimmunocomplexes were visualized using chemiluminescent
blotting reagent (Pierce, USA) and X-ray film (18 × 24 cm;
Kodak).
Differential image and data analysis
We utilized LabScan image scanner (version 5; Amersham,
Germany) to capture and store the 2-DE gel images.
PD-Quest™ 2-D gel analysis software (Version 8.0.1,
Bio-Rad) was used to detect, match, and quantify the
distinct protein spots. In order to identify differentially
expressed serum proteins, the percentages of volume
contributions (vol%) were calculated (i.e., the spot vol-
ume of a specific protein as a percentage of the total
spot volume of all proteins in the gel, including unre-
solved peptides).
Statistical analysis
Protein levels in the gels are presented as mean vol% ±
SD (standard deviation). The variance ratio test (F) was
used to analyse differences between control subjects and
patients. Correlations between the variables were exam-
ined using GraphPad Prism 5 software. A p-value of less
than 0.05 was considered as statistically significant.
Functional enrichment and protein interaction analysis
Functional enrichment and protein interactions were
analysed using web-based bioinformatics tools. DAVID
v6.7 (Database for Annotation, Visualization and Inte-
grated Discovery) was employed for protein functional
enrichment analysis [15,16]. DAVID bioinformatics pro-
vide a comprehensive biological knowledgebase of func-
tional annotation tools for understanding the biological
meaning behind large lists of genes or proteins. The
functional categorization is considered significant when
the p-value is less than 0.05. The identified host-specific
proteins were further evaluated using STRING v9.1
(Search Tool for the Retrieval of Interacting Genes),
which is an application that aggregates available data-
bases of known and predicted protein–protein associa-
tions [17].
Results
Differential expression of antigenic proteins
We have performed a 2-DE assay that allowed for rapid
detection and differentiation of P. knowlesi from other
Plasmodium species. We first separated unfractionated
normal control sera samples with 2-DE and observed
high-resolution profiles, which were made up of several
distinct protein clusters (Figure 1a). Sera samples from P.
knowlesi-infected patients, presumably containing P. know-
lesi antigens, were also separated by 2-DE (Figure 1b). Sub-
sequently, the 2-DE profiles from these patients were
compared with those obtained from normal individuals, re-
vealing key differences in the expression of several serum
Figure 1 Representative 2-DE serum protein profiles for (a)
control (b) P. knowlesi-infected individuals. Unfractionated serum
samples from patients and controls were subjected to 2-DE and silver
stained. Protein spots were compared and analysed using PD-Quest™
2-D gel analysis software (version 8.0.1, Bio-Rad).
Table 1 The relative expression of host specific proteins
among the sera of malaria patients
Host specific proteins Fold changes
1. Alpha-2-HS glycoprotein (AHSG) 1.28
2. Serotransfererrin (TF) 1.15
3. Complement C3c (C3) 8.99
4. Hemopexin (HPX) 1.60
5. Zinc-2-alpha glycoprotein (ZAG1) 3.40
6. Haptoglobin (HAP) 0.42
7. Apolipoprotein A-I (Apo-A1) 0.34
8. Alpha-1-B-glycoprotein (A1BG) 0.53
Fold change measures the degree of change in the protein of the P. knowlesi-
infected individuals (n = 9), compared to normal controls (n = 23). This is
measured by dividing the average spot intensity in the infected persons by
the average spot intensity in the controls.
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tein spots/clusters that appeared to undergo up- or down-
regulation (Figure 1b).
Identification of expressed biomarkers by mass
spectrometry
We analysed the protein clusters using PD-Quest TM
2-DE gel analysis software (version 8.0.1, Bio-Rad),
which indicated that there were a total of 200 and 124
protein spots detected by 2-DE for the P. knowlesi and
normal samples, respectively. Therefore, 76 protein
spots were differentially observed in malaria knowlesi
sera compared to normal controls.
We further identified the following differentially-
expressed host-specific proteins by MS: alpha-2-HS
glycoprotein (AHSG), serotransferrin (TF), complement
C3c (C3), hemopexin (HPX), zinc-2-alpha glycoprotein
(ZAG1), apolipoprotein A1 (Apo-A1), haptoglobin (HAP),
and alpha-1-B-glycoprotein (A1BG). All of the proteins
were aberrantly expressed in patient samples as compared
to normal controls. Indeed, as shown in the Table 1, we
observed significant increases in C3, ZAG1, HPX, AHS,
and TF during knowlesi malaria infection (fold up-
regulation: 8.99, 3.40, 1.60, 1.25, and 1.15, respectively;
p < 0.05). On the other hand, the expression of HAP,
Apo-A1, and A1BG were significantly decreased (fold
down-regulation: 0.42, 0.34, and 0.53; p < 0.05) inknowlesi samples (Figure 1a-b). Additionally, we de-
tected the following malaria-specific antigens: K15,
K16, K17, K23, K26, K28, K29, K30, K32 K33, and K38
(Tables 1, 2, and 3).
The above results were confirmed through the use of
MALDI-TOF/TOF and database searches. The Plas-
moDB database was employed to blast MS/MS-identified
peptides against the hypothetical P. knowlesi H strain
proteome, which is only comprised of computationally
predicted sequences [18]. This database contains the
genomes of various mammalian Plasmodium species
(P. falciparum, P. knowlesi, P. vivax, and P. yoelii),
which range from 23 to 27 Mb across 14 chromosomes
and comprise approximately 5,500 genes (http://plas-
modb.org/plasmo/). A remarkable 77% of these genes
represent orthologous between these four species, and
almost one-half of the genes encode conserved hypo-
thetical proteins of unknown function. However, although
PlasmoDB contains the most up-to-date annotation on P.
knowlesi sequences, it is incomplete. Thus, it cannot be
ruled out that some genes may be missing or incorrectly
annotated in the PlasmoDB database. For this reason, ex-
perimental verification will be needed to assess whether
current data offer a comprehensive view of the Plasmodium
proteome, especially in the case of P. knowlesi. Neverthe-
less, our findings provide evidence to support the existence
of some of these predicted sequences. The Mascot acces-
sion numbers, isoelectric points (pI), and molecular mass
(Mr) values associated with the identified proteins are listed
in Tables 4 and 5.
Detection of immunocomplexed biomarkers by 2-DE
immunoblotting
In order to confirm the 2-DE image analysis and MS re-
sults, we performed immunoblotting with pooled patient
sera (anti-P. knowlesi antibodies). Specifically, our immuno-
blotting analysis involved five distinct conditions to allow
Table 3 Antigenic proteins show on the 2-DE
immunoblotted nitrocellulose membrane
Antigenic
proteins
Category
(a) (b) (c) (d) (e)
1. K15 - - - (/) -
2. K16 - - - (/) -
3. K17 - - - - /
4. K23 - - - - /
5. K26 - - - - /
6. K28 - - - (/) -
7. K29 - - - (/) -
8. K30 - - - (/) -
9. K32 - - - / /
10. K33 - - - / /
11. K38 - - - (/) -
(/)Antigens specifically detected in the knowlesi serum.
/Proteins of the patients or normal pooled serum recognized by the
primary antibody.
-Proteins of the patients or normal pooled serum not recognized by the
primary antibody.
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mal sera and sera from P. vivax-infected patients. The fol-
lowing conditions were tested (categories a–e): (a) normal
pooled sera probed with normal pooled sera, (b) normal
pooled sera probed with P. knowlesi pooled sera, (c) P.
knowlesi pooled sera probed with normal pooled sera, (d)
P. knowlesi pooled sera probed with P. knowlesi pooled sera,
(e) P. knowlesi pooled sera probed with P. vivax pooled sera
are displayed in Figures 2 and 3. Immunoblotting of 2-DE
membranes revealed significant variations in the control
(Figure 2a, b) and patient (Figures 2c, d and 3) sera profiles.
In Figure 2, only categories ‘a’ (negative control) and ‘c’
(positive control) failed to show immunogenic spots. How-
ever, the remaining categories (Figures 2b, d, and 3) re-
vealed many immunogenic host-specific and malaria
antigens. Strikingly, we could specifically distinguish differ-
ences when immunoblotting vivax malaria patients with
sera from knowlesi-infected patients.
Immunogenic host-specific proteins are displayed in
Table 2. Some of these malaria serum-reactive proteins
could be detected in both non-infected and infected
serum, including AHSG, A1BG, and Apo-AI (Figure 2b,
d). However, ZAG1 and C3 appeared prominently for
both individual patients in categories d and e. In
addition, the A1BG signal was observed in categories d
and e. Notably, HAP was the only protein that showed
immunogenicity in category ‘e’ but not in category ‘d’.
TF was detected in category ‘d’. HPX only appeared in
the category ‘d’ immunoblot, whereas HRG was exclu-
sively observed in category ‘e’.
With regard to malaria antigens, immunogenic spots
for K15, K16, K28, K29, K30, and K38 were specific to P.
knowlesi, as they could not be detected with antibodies
from P. vivax-infected patients (Table 3 and Figure 3).
However, only K15, K28, K30, and K38 were consideredTable 2 Host antigenic proteins show on the 2-DE
immunoblotted nitrocellulose membrane
Host
antigenic
proteins
Category
(a) (b) (c) (d) (e)
1. AHSG - / - / /
2. TF - - - / -
3. C3 - - - / /
4. HPX - - - / -
5. ZAG1 - - - / /
6. HAP - - - - /
7. Apo-A1 - / - / /
8. A1BG - / - / /
9. HRG - - - - /
/Proteins of the patients or normal pooled serum recognized by the
primary antibody.
-Proteins of the patients or normal pooled serum not recognized by the
primary antibody.to be significant (i.e., search score of > 30). These four
novel antigens were observed in 6 (66.7%), 5 (55.6%), 8
(95.1%), and 9 (100%) of the stained 2-DE gels, showing
an average vol% of 0.00638, 0.00589, 0.04782, and
0.08956 (K15, K28, K30 and K38, respectively).
Functional enrichment and protein interaction analysis
In order to extend the above results, we employed DAVID
v6.7 (http://david.abcc.ncifcrf.gov/) to perform functional
ontology enrichment analyses (i.e., biological processes,
molecular functions, cellular components, and pathways)
for 11 significantly identified proteins (Table 6). This func-
tional analysis revealed that AHSG, C3, and histidine-rich
glycoprotein precursor (HRG) were involved in regulating
responses to external stimuli, whereas HAP, HPX and TF
participated in iron homeostasis. In addition, molecular
function analysis showed that AHSG, C3 and HRG play a
role in endopeptidase and peptidase inhibitor activity. Also,
the majority of the proteins were located in the extracellular
region. However, cellular components analysis revealed that
Apo-A1, fibrinogen γ chain (FGG), HRG, and TF could be
found in secretory granules and membrane-bound vesicles.
In addition, KEGG pathway analysis indicated significant
participation of C3 and FGG in complement and coagula-
tion cascades pathways (p = 0.026957).
The STRING database (http://string-db.org/) is a curetted
knowledge database that relies on evidence from high-
throughput proteomic, genomic, and co-expression studies
[19]. We performed protein interaction analysis using this
database, which revealed an interaction network involving
the identified host-specific proteins (AHSG, TF, C3, HPX,
ZAG1, HAP, Apo-A1, HRG, A1BG, FGG and LRG1)
Table 4 Mass spectrometric identification of host-specific protein spot clusters from serum protein profiles using
MASCOT search engine and NCBI database
Spot ID Mascot accession
number
pI Theoretical
mass (Da)/pI
Sequence
coverage
Search
score
Queries
match
Expected
value
1. Chain C, Human Complement Component C3c
(C3)
gi|78101271 4.79 40217 10% 218 6 1.8e−015
2. Transferrin (TF) gi|553788 6.00 55233 13% 82 10 0.082
3. Chain A, Crystal Structure Of Lipid-Free Human
Apolipoprotein A-I (ApoA1)
gi|90108664 5.27 28061 62% 357 26 2.3e−029
4. Leucine-rich α2-glycoprotein precursor [Homo
sapiens] (LRG1)
gi|16418467 6.45 38382 31% 358 16 1.8e−029
5. Hemopexin, isoform CRA_d [Homo sapiens]
(HPX)
gi|119589127 6.24 43781 13% 112 8 7.3e−005
6. α1-B-glycoprotein (A1BG) gi|69990 5.65 52479 39% 449 20 1.5e−038
7. α2-HS-glycoprotein, isoform CRA_b [Homo
sapiens] (AHSG)
gi|119598594 4.81 23148 6% 121 2 9.2e−006
8. Haptoglobin [Homo sapiens] (HAP) gi|3337390 6.14 38722 28% 202 15 7.3e−014
9. Histidine-rich glycoprotein precursor [Homo
sapiens] (HRG)
gi|4504489 7.09 60510 13% 114 10 4.6e−005
10. Chain B, Human Zinc-α2-glycoprotein (ZAG1) gi|4699583 5.70 31854 51% 523 22 5.8e−046
11. Fibrinogen gamma chain (FGG) gi|930064 6.49 24337 45% 56 10 33
Table 5 Mass spectrometric identification of unknown protein spot clusters from serum protein profiles using MASCOT
search engine, NCBI database and Plasmo DB
Spot ID Mascot accession
number
ID pI Theoretical
mass
(Da)/pI
Sequence
coverage
Search
score
Queries
match
Expected
valueNumber
Plasmodium_knowlesi_strain_H | product = hypothetical
protein, conserved in Apicomplexan s
psu|PKH_030860 K15 8.42 57570 16% 37 8 1.1
Plasmodium_knowlesi_strain_H | product = conserved
Plasmodium protein, unknown function
psu|PKH_050250 K16 9.20 52407 1% 26 2 13
Plasmodium_knowlesi_strain_H | product = dynein light
chain 1, putative | location = Pk_stra
psu|PKH_050850 K17 8.75 23061 34% 34 7 2.1
Plasmodium_knowlesi_strain_H | product = conserved
Plasmodium protein, unknown function |
psu|PKH_093010 K23 5.08 32237 34% 46 10 0.13
Plasmodium_knowlesi_strain_H | product = translation
intiation factor IF-2 | location = Pk_s
psu|PKH_050380 K24 8.77 137165 5% 28 12 7.7
Plasmodium_knowlesi_strain_H | product = conserved
Plasmodium protein
PKH_050250 K26 9.20 52407 1% 29 2 6.9
Plasmodium_knowlesi_strain_H | product = conserved
Plasmodium protein, unknown function
psu|PKH_091010 K28 8.32 20628 8% 38 3 0.82
Plasmodium_knowlesi_strain_H | product = conserved
Plasmodium protein, unknown function
psu|PKH_050250 K29 9.20 52407 1% 15 2 1.6e+002
Plasmodium_knowlesi_strain_H | product = conserved
Plasmodium protein, unknown function
psu|PKH_091010 K30 8.32 20628 8% 32 3 8.32
Plasmodium_knowlesi_strain_H | product = SOH1
homologue, putative | location = Pk_strainH_ch
psu|PKH_126910 K32 6.90 16303 20% 42 9 0.37
Plasmodium_knowlesi_strain_H | product = hypothetical
protein, conserved in Apicomplexan s
psu|PKH_031640 K33 9.43 9570 24% 25 3 18
Plasmodium_knowlesi_strain_H | product =
dihydrolipoamide dehydrogenase, putative | ocate
psu|PKH_051660 K37 9.21 74131 1% 16 2 1.2e+002
Plasmodium_knowlesi_strain_H | product = conserved
Plasmodium protein, unknown function
psu|PKH_050250 K38 9.20 52407 1% 31 2 4.4
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Figure 2 Western blot results following 2-DE. (a) normal pooled sera probed with normal pooled sera, (b) normal pooled sera probed with
P. knowlesi pooled sera, (c) P. knowlesi pooled sera probed with normal pooled sera, (d) P. knowlesi pooled sera probed with P. knowlesi pooled
sera, Unfractionated, pooled serum samples from patients and normal controls were subjected to 2-DE, transferred onto nitrocellulose
membranes, and probed with pooled sera (as primary antibody) followed by monoclonal anti-human IgM-HRP (as secondary antibody).
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an established association with the Apo-A1-dominated net-
work. Indeed, 10 protein partners (ABCA1, APOA2,
APOB, APOC3, CFH, F2, FGA, FGB, LCAT, and TFRC)
were predicted to be part of this functional interaction.
Discussion
The global impact of malaria has sparked interest in de-
veloping effective diagnostic strategies, which are not
only essential for resource-limited areas where malaria is
a substantial societal burden, but also for developed
countries [18,20]. In theory, the detection of malaria par-
asites or antigens in patient blood should be simple.
However, diagnostic efficacy is subject to many import-
ant variables, including the various stages of erythrocytic
schizogony, species endemicity, interrelationship be-
tween levels of transmission, population movement,
parasitemia, immunity, and species-specific symptoms [11].
Among the Plasmodium species, detection of P. know-
lesi is the most challenging due to morphological simi-
larities and physical co-localization of genetic loci on
the same chromosome within an individual or species.
In this respect, Carlton et al. was the first to generate
and compare a synteny map of P. falciparum, P. vivax,
P. knowlesi, and the rodent malaria parasites (P. yoelii,P. berghei, and P. chabaudi) [19]. Overall, high synteny
was observed between P. vivax and P. knowlesi chro-
mosomes, with the exception of microsyntenic breaks
in species-specific genes (e.g., P. knowlesi kir and
SICAvar) [21]. These breaks were recognized as foci
involved in the evolution of host–parasite interaction
genes [22].
Proteomic analysis by 2-DE has been widely used to
identify specific bacterial or viral antigens during vaccine
and/or serodiagnostic test development [23]. Neverthe-
less, there have been few proteomic studies focused at
elucidating pathogenic mechanisms or identifying poten-
tial diagnostic markers in malaria [24-26]. In the present
study, we have analysed serum samples from infected in-
dividuals to identify and characterize novel markers of
malaria infection using 2-DE coupled with immunoblot-
ting techniques and mass spectrometry analysis. It is
known that the immune response is relative with the pres-
ence of parasite density. Therefore, the immunoproteo-
mics approach used in this study can be applied to identify
antigens targeted by the immune system that response to
infection. In addition, several studies have also reported
on the protective role of IgM in the immune response
during malaria infection [27,28]. Thus, both the host pro-
teins and P. knowlesi antigens, represents the potential
Figure 3 Western blot of P. knowlesi pooled sera probed with P. vivax pooled sera. Unfractionated, pooled serum samples from patient is
subjected to 2-DE, transferred onto nitrocellulose membranes, and probed with pooled sera (as primary antibody) followed by monoclonal
anti-human IgM-HRP (as secondary antibody).
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ment of future diagnostic tools for P. knowlesi.
It has been suggested that invasion of erythrocytes by
malaria parasites involves specific interactions between
parasite receptors and erythrocyte ligands [29,30]. For
this process, glycoproteins on the parasite receptors bind
to hydrophobic peptides on the surface of humanTable 6 Functional enrichment classification of identified hos
Enrichment s
Biological process Regulation of response to external
stimulus
2.3
Cellular iron ion homeostasis 2.13
Iron ion homeostasis 2.13
Cellular di-, tri-valent inorganic cation
homeostasis
2.13
Di-, tri-valent inorganic cation
homeostasis
2.13
Cellular cation homeostasis 2.13
Molecular function Endopeptidase inhibitor activity 2.3
Peptidase inhibitor activity 2.3
Enzyme inhibitor activity 2.3
Cellular component Extracellular region 8.11
Secretory granule 2.31
Cytoplasmic membrane-bounded
vesicle
2.31
Membrane-bounded vesicle 2.31
Cytoplasmic vesicle 2.31
+The classification stringency was set to high.erythrocytes. Thus, hydrophobic peptides, which can be
found in the form of sialic acid-rich regions, could make
cells susceptible to infection by creating a negative
charge at the surface [29]. Based on our findings, TF,
HPX and HAP constitute very selective biomarkers for
malaria infection. These three proteins are known as
iron-binding glycoproteins which are involved in thet-specific proteins using DAVID bioinformatics tool
core+ Protein count (%) Protein ID P value
3 (27.27) AHSG, C3, HRG 4.69e-3
3 (27.27) HAP, HPX, TF 1.81e-4
3 (27.27) HAP, HPX, TF 2.45e-4
3 (27.27) HAP, HPX, TF 9.34e.3
3 (27.27) HAP, HPX, TF 1.03e-2
3 (27.27) HAP, HPX,TF 1.16e-2
3 (27.27) AHSG,C3, HRG 3.32e-3
3 (27.27) AHSG, C3, HRG 3.69e-3
3 (27.27) AHSG, C3, HRG 1.11e-2
11 (100) A1BG, AHSG, APOA1, AZGP1, C3,
FGG, HAP, HPX, HRG, LRG1, TF
2.66e-11
4 (36.36) APOA1, FGG, HRG, TF 3.06e-4
4 (36.36) APOA1, FGG, HRG, TF 7.58e-3
4 (36.36) APOA1, FGG, HRG, TF 8.29e-3
4 (36.36) APOA1, FGG, HRG, TF 1.16e-2
Figure 4 Interaction networks of identified host specific
proteins using STRING v9.1. STRING database is a curated
knowledge database that relies on various evidences from high-
throughput proteomic, genomic and co-expression studies. The
predicted functions of proteins are shown.
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the innate immune response [31].
Iron is essential for the development of malaria para-
site. It is known that Plasmodium parasites synthesize
their own TF receptors, which can become localized on
the surface of infected cells [32-34]. The delivery of
extracellular iron from TF to infected erythrocytes is the
source of ferric ions for malaria parasites. The alteration
of TF level may influence the balance between inhibiting
and promoting the survival of malaria parasite [35].
Thus, it is possible that P. knowlesi and P. vivax directly
secrete TF to gain access to iron through receptor-
mediated endocytosis.
Notably, it was reported that iron deficiency induces
TF receptor expression and doubles the number of
HPX surface receptors (subsequently increasing HPX-
mediated heme uptake in vitro) [36]. Under homeosta-
sis, HPX can scavenge most of the free heme to form
heme-HPX complex which prevent the onset of malaria
[37]. Interestingly, some bacterial species, such as Hae-
mophilus influenzae, Campylobacter jejuni, and Yersinia
pestis [38-41], possess specialized iron acquisition systems
for survival in hosts and are capable of heme uptake
through heme–HPX complexes. Although the heme up-
take activity is not parasite specific, it is possible that a
similar survival system might be utilized by Plasmodium
species. The expression of HPX has also been identified
in several malaria studies, where this protein provides
the support line of defence against haemoglobin-
mediated oxidative damage during intravascular haem-
olysis [30,42].Additionally, our results have demonstrated that HAP
is downregulated in malaria patients. However, HAP was
only antigenic in sera from P. vivax-infected individuals
and not from P. knowlesi-infected patients. High HAP
expression can reduce symptoms associated with malaria
by causing toxicity to Plasmodium parasites [43] and by
removing free haemoglobin (Hb) following Plasmodium-
triggered haemolysis. In this regard, evidence has indi-
cated that a higher peak of parasitemia and/or parasite
burden was found in P. berghei (ANKA)- or Plasmodium
chabaudi-infected mice compared to that of wild type
[44]. In short, decreased expression of HAP could con-
tribute to the life-threatening levels of parasitemia ob-
served in P. knowlesi-infected patients.
Conclusions
In summary, we have demonstrated the application of
immunoproteomics approach to understand the immune
response and identify potential candidate biomarkers for
knowlesi malaria infection. Taken together, we have spe-
cifically identified TF, HPX and HAP as antigenic
markers in P. knowlesi. A further investigation on the
functional roles of the identified potential biomarkers in
larger clinical samples will be valuable to enhance our
current understanding of P. knowlesi and to develop ef-
fective diagnostic tools to detect knowlesi malaria.
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